Adiponectin and Circulating Progenitor Cells (CPC) Function
Adiponectin Promotes the Migration of Circulating Progenitor Cells Through p38-mediated Induction of the CXCR4 Receptor
1 other identifier
interventional
20
1 country
1
Brief Summary
Adiponectin and exercise training contribute to the maintenance of a normal vascular tone by influencing vascular NO bioavailability and concentration and function of endothelial progenitor cells. The molecular mechanisms are only partially understood. Therefore, aim of the present study is to elucidate the effects of Adiponectin on endothelial progenitor cell migration and the underlying signaling pathways. Furthermore, the impact of exercise training on adiponectin-mediated endothelial progenitor cell migration will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 coronary-artery-disease
Started Jan 2011
Shorter than P25 for phase_1 coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 7, 2011
CompletedFirst Posted
Study publicly available on registry
January 10, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJune 2, 2015
June 1, 2015
2 months
January 7, 2011
June 1, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
migratory capacity of endothelial progenitor cells towards an SDF-1 gradient
4 weeks
Study Arms (3)
exercise training
ACTIVE COMPARATOR4 weeks of supervised physical exercise training
control
NO INTERVENTIONsedentary lifestyle
healthy control
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- ≤ 75 years of age
- stable coronary artery disease
- preserved left ventricular function
- physical work capacity of ≥ 50
- successful elective percutaneous coronary intervention at study begin
You may not qualify if:
- diabetes mellitus
- hypercholesterolemia
- untreated hypertension
- smoking
- myocardial infarction within the last 4 weeks
- significant stenosis of the left main coronary artery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leipziglead
- German Research Foundationcollaborator
- Heart Center Leipzig - University Hospitalcollaborator
Study Sites (1)
University of Leipzig, Heart Center
Leipzig, 04289, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Axel Linke, MD
Heart Center Leipzig - University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-investigator
Study Record Dates
First Submitted
January 7, 2011
First Posted
January 10, 2011
Study Start
January 1, 2011
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
June 2, 2015
Record last verified: 2015-06